Logo-bi
Original Research
Bahman Hosseini*, Haleh Hashemi*, Farajollah Shahriari Ahmadi, Mohammad Hasan Marashi, Mahdi Mohseniazar
Bioimpacts. 2011;1(4): 229-235. doi: 10.5681/bi.2011.033
PMCID: PMC3648975     PMID: 23678433     Scopus ID: 84876723236    
PDF
XML
Cited By:
Short Communication
Soheila Rezapour-Firouzi, Seyed Rafie Arefhosseini*, Mehdi Farhoudi, Mehrangiz Ebrahimi-Mamaghani, Mohammad-Reza Rashidi, Mohammad-Ali Torbati, Behzad Baradaran
Bioimpacts. 2013;3(1): 43-47. doi: 10.5681/bi.2013.001
PMCID: PMC3648912     PMID: 23678469     Scopus ID: 84879193741    
PDF
XML
Cited By:
Original Research
Himan Heidari, Mohammad Kamalinejad, Maryam Noubarani, Mokhtar Rahmati, Iman Jafarian, Hasan Adiban, Mohammad Reza Eskandari*
Bioimpacts. 2016;6(1): 33-39. doi: 10.15171/bi.2016.05
PMCID: PMC4916550     PMID: 27340622     Scopus ID: 84977156856    
Original Research
Azam Safary ORCID, Rezvan Moniri, Maryam Hamzeh-Mivehroud, Siavoush Dastmalchi*
Bioimpacts. 2019;9(1): 15-23. doi: 10.15171/bi.2019.03
PMCID: PMC6378094     PMID: 30788256     Scopus ID: 85060439417    
The current study introduces a new and efficient recombinant L-asparaginase (ASPase) enzyme from locally isolated halo-thermotolerant Bacillus. The activity assay of ASPase A1 and ASPase A3 showed that only ASPase A1 is an active and stable homologues enzyme with high substrate affinity toward L-asparagine.
Retraction
Zohreh Ebrahimnezhad, Nosratollah Zarghami*, Manoutchehr Keyhani, Soumaye Amirsaadat, Abolfazl Akbarzadeh, Mohammad Rahmati, Zohreh Mohammad Taheri, Kazem Nejati-Koshki
Bioimpacts. 2018;8(4): 321. doi: 10.15171/bi.2018.34
PMCID: PMC6209827     PMID: 30397586     Scopus ID: 85056145531    
Original Research
Siamak Alizadeh, Abolfazl Barzegari, Abolghasem Esmaeili*, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(3): 187-193. doi: 10.34172/bi.2020.23
PMCID: PMC7416006     PMID: 32793441     Scopus ID: 85089711371    
E. coli Nissle 1917 (EcN) is proposed as an appropriate light-activated vehicle for delivery of anticancer agents to the cancer cells/tissues such colorectal cancer.
LPS stimulated the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 by binding toTLR-4. iNOS produced enormous nitric oxide (NO) that stimulated COX-2 activity and prostaglandin E2 which further induced the production of pro-inflammatory cytokines leading to inflammation. ALK-F of A. vasica could attenuate iNOS and COX-2 gene expression reducing NO production.
Original Research
Jeanne Akissi Koffi* ORCID, Kigbafori Dieudonné Silué, Dominique Konan Tano, Trésor Marius Dable, William Yavo
Bioimpacts. 2020;10(3): 151-157. doi: 10.34172/bi.2020.19
PMCID: PMC7416013     PMID: 32793437     Scopus ID: 85089707941    
The antiplasmodial properties of these plants could partially justify their use in malaria treatment.
Original Research
G Divyashri* ORCID, T P Krishna Murthy, Subramaniam Sundareshan, Pavan Kamath, Manikanta Murahari*, G R Saraswathy, Bindu Sadanandan
BioImpacts. 2021;11(2): 119-127. doi: 10.34172/bi.2021.19
PMCID: PMC8022237     PMID: 33842282     Scopus ID: 85106557158    
Novel inhibitors from Mango ginger were identified against five drug targets of H. pylori. In silico potential of Mango ginger compound, gentisic acid with the drug target, shikimate kinase was evaluated. Results were found promising without any limitations.
Original Research
Solmaz Zakhireh ORCID, Jaleh Barar* ORCID, Younes Beygi-Khosrowshahi, Abolfazl Barzegari, Yadollah Omidi, Khosro Adibkia* ORCID
BioImpacts. 2022;12(3): 183-193. doi: 10.34172/bi.2021.24
PMCID: PMC9124872     PMID: 35677670     Scopus ID: 85132071807    
The pollen grain of Pistacia vera L. is proposed as a scaffolding building block with the encapsulation capability of bioactive compounds. A modified simple method was developed to create nonallergic hollow pollen grains (HPGs).
Review
Luigi X Cubeddu* ORCID, Daisy de la Rosa, Michele Ameruoso
Bioimpacts. 2022;12(1): 9-20. doi: 10.34172/bi.2021.23630
PMCID: PMC8783084     PMID: 35087712     Scopus ID: 85127123894    
A combination of old age, comorbidities, increased cytokine levels and proarrhythmic drug therapies canexplain the increased arrhythmic events reported in severe COVID-19 disease.
Original Article
Firooz Safaefar ORCID, Javad Karamdel* ORCID, Hadi Veladi* ORCID, Masoud Maleki ORCID
Bioimpacts. 2024;14(4): 28902. doi: 10.34172/bi.2023.28902
PMCID: PMC11298026     PMID: 39104621    


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge